Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 14 studies | 27% ± 11% | |
peripheral blood | 13 studies | 30% ± 14% | |
brain | 10 studies | 28% ± 14% | |
intestine | 7 studies | 25% ± 11% | |
kidney | 5 studies | 18% ± 2% | |
eye | 5 studies | 23% ± 3% | |
bone marrow | 4 studies | 31% ± 13% | |
lymph node | 4 studies | 25% ± 8% | |
liver | 4 studies | 36% ± 14% | |
pancreas | 3 studies | 24% ± 10% | |
placenta | 3 studies | 32% ± 10% | |
uterus | 3 studies | 38% ± 16% | |
breast | 3 studies | 26% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 6903.10 | 21 / 21 | 100% | 45.12 | 504 / 504 |
breast | 100% | 6226.48 | 459 / 459 | 100% | 53.90 | 1118 / 1118 |
esophagus | 100% | 6881.43 | 1445 / 1445 | 100% | 62.69 | 183 / 183 |
intestine | 100% | 7221.47 | 966 / 966 | 100% | 47.81 | 527 / 527 |
liver | 100% | 3971.77 | 226 / 226 | 100% | 28.08 | 406 / 406 |
lung | 100% | 6609.01 | 578 / 578 | 100% | 50.16 | 1155 / 1155 |
ovary | 100% | 5496.51 | 180 / 180 | 100% | 52.37 | 430 / 430 |
prostate | 100% | 5968.02 | 245 / 245 | 100% | 44.48 | 502 / 502 |
stomach | 100% | 5235.18 | 359 / 359 | 100% | 47.64 | 286 / 286 |
thymus | 100% | 11458.62 | 653 / 653 | 100% | 63.26 | 605 / 605 |
uterus | 100% | 6427.31 | 170 / 170 | 100% | 52.75 | 459 / 459 |
brain | 100% | 5379.96 | 2640 / 2642 | 100% | 46.15 | 705 / 705 |
kidney | 100% | 4952.85 | 89 / 89 | 100% | 39.24 | 900 / 901 |
pancreas | 100% | 3123.92 | 327 / 328 | 100% | 41.87 | 178 / 178 |
adrenal gland | 100% | 6110.35 | 258 / 258 | 100% | 34.74 | 229 / 230 |
skin | 100% | 6979.07 | 1809 / 1809 | 99% | 43.65 | 465 / 472 |
adipose | 100% | 6359.19 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7249.96 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 46.51 | 29 / 29 |
muscle | 100% | 5983.53 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6428.61 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 49.64 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 32.69 | 1 / 1 |
heart | 99% | 3767.25 | 853 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 27.96 | 77 / 80 |
peripheral blood | 95% | 3988.60 | 880 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007283 | Biological process | spermatogenesis |
GO_0045995 | Biological process | regulation of embryonic development |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0034644 | Biological process | cellular response to UV |
GO_0048593 | Biological process | camera-type eye morphogenesis |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0010225 | Biological process | response to UV-C |
GO_0045739 | Biological process | positive regulation of DNA repair |
GO_0071707 | Biological process | immunoglobulin heavy chain V-D-J recombination |
GO_0006282 | Biological process | regulation of DNA repair |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0006974 | Biological process | DNA damage response |
GO_1902894 | Biological process | negative regulation of miRNA transcription |
GO_0060382 | Biological process | regulation of DNA strand elongation |
GO_1904507 | Biological process | positive regulation of telomere maintenance in response to DNA damage |
GO_0071347 | Biological process | cellular response to interleukin-1 |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006338 | Biological process | chromatin remodeling |
GO_0061052 | Biological process | negative regulation of cell growth involved in cardiac muscle cell development |
GO_0000724 | Biological process | double-strand break repair via homologous recombination |
GO_0030183 | Biological process | B cell differentiation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0034696 | Biological process | response to prostaglandin F |
GO_0000723 | Biological process | telomere maintenance |
GO_0009952 | Biological process | anterior/posterior pattern specification |
GO_0033044 | Biological process | regulation of chromosome organization |
GO_0032688 | Biological process | negative regulation of interferon-beta production |
GO_0006275 | Biological process | regulation of DNA replication |
GO_0006403 | Biological process | RNA localization |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0031519 | Cellular component | PcG protein complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005677 | Cellular component | chromatin silencing complex |
GO_0016363 | Cellular component | nuclear matrix |
GO_0000785 | Cellular component | chromatin |
GO_0031011 | Cellular component | Ino80 complex |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000987 | Molecular function | cis-regulatory region sequence-specific DNA binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0046332 | Molecular function | SMAD binding |
GO_0000400 | Molecular function | four-way junction DNA binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0001217 | Molecular function | DNA-binding transcription repressor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | YY1 |
Protein name | Transcriptional repressor protein YY1 (Delta transcription factor) (INO80 complex subunit S) (NF-E1) (Yin and yang 1) (YY-1) YY1 transcription factor |
Synonyms | INO80S |
Description | FUNCTION: Multifunctional transcription factor that exhibits positive and negative control on a large number of cellular and viral genes by binding to sites overlapping the transcription start site . Binds to the consensus sequence 5'-CCGCCATNTT-3'; some genes have been shown to contain a longer binding motif allowing enhanced binding; the initial CG dinucleotide can be methylated greatly reducing the binding affinity . The effect on transcription regulation is depending upon the context in which it binds and diverse mechanisms of action include direct activation or repression, indirect activation or repression via cofactor recruitment, or activation or repression by disruption of binding sites or conformational DNA changes . Its activity is regulated by transcription factors and cytoplasmic proteins that have been shown to abrogate or completely inhibit YY1-mediated activation or repression . For example, it acts as a repressor in absence of adenovirus E1A protein but as an activator in its presence . Acts synergistically with the SMAD1 and SMAD4 in bone morphogenetic protein (BMP)-mediated cardiac-specific gene expression . Binds to SMAD binding elements (SBEs) (5'-GTCT/AGAC-3') within BMP response element (BMPRE) of cardiac activating regions . May play an important role in development and differentiation. Proposed to recruit the PRC2/EED-EZH2 complex to target genes that are transcriptional repressed . Involved in DNA repair . In vitro, binds to DNA recombination intermediate structures (Holliday junctions). Plays a role in regulating enhancer activation . .; FUNCTION: Proposed core component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair; proposed to target the INO80 complex to YY1-responsive elements. . |
Accessions | ENST00000553625.5 ENST00000704485.1 ENST00000262238.10 A0A494C032 ENST00000554804.1 A0A994J726 H0YJU4 ENST00000554371.1 G3V3M8 P25490 ENST00000651219.1 H0YJV7 |